During the past decade, Akita University Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 20 clinical trials were completed, i.e. on average, 60.6% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 14 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Akita University Hospital" #1 sponsor was "Pfizer" with 19 trials, followed by "Celgene" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Ferring Pharmaceuticals" with 2 trials sponsored and "Janssen Pharmaceutical K.K." with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Akita University Hospital" #1 collaborator was "UCB Pharma" with 2 trials as a collaborator, "Japan Breast Cancer Research Group (JBCRG)" with 1 trials as a collaborator, "Japan Lung Cancer Society" with 1 trials as a collaborator, "Korean Cancer Study Group" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Akita University Hospital" are "Acute Myeloid Leukemia" (3 trials), "Carcinoma, Renal Cell" (3 trials), "Chronic Myeloid Leukemia" (2 trials), "Eosinophilic Esophagitis" (2 trials) and "Lymphoma, Large B-Cell, Diffuse" (2 trials). Many other conditions were trialed in "Akita University Hospital" in a lesser frequency.

Most popular intervention types in "Akita University Hospital" are "Drug" (43 trials), "Other" (4 trials), "Biological" (3 trials), "Procedure" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Apalutamide" (2 trials), "Axitinib (AG-013736)" (2 trials), "Bosutinib" (2 trials) and "CC-93538" (2 trials). Other intervention names were less common.

The vast majority of trials in "Akita University Hospital" are 45 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Akita University Hospital". undefined are not yet recruiting, 8 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Akita University Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Akita University Hospital, 4 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".